HEP Dynamics

https://fb.watch/4bg2eyfvSf/

Follow Surfing The NASH Tsunami Podcast for regular updates in the discussion of #FattyLiver, #NASH, and #NAFLD

Follow Surfing The NASH Tsunami Podcast to stay informed on the discussion in Fatty Liver Disease. https://www.facebook.com/100219462043696/posts/114268170638825/

Follow SurfingNASH to stay up-to-date with all things discussed about Fatty Liver Disease. https://www.facebook.com/permalink.php?story_fbid=111791930886449&id=100219462043696

What we will discuss regarding today's FDA Webcast Phase 2 drug development for NASH Clinical trial inclusion/exclusion for phase 3 NASH trials Surrogate efficacy endpoints that have been acknowledged by FDA as reasonably likely to predict clinical benefit... Clinical endpoints for the confirmation of clinical benefit Strategies at clinical drug development for NASH WHERE https://bit.ly/NASH-Podcast-Apple #healthcare #webinar #fda #digitalhealth #biotech #healthtech #NASH #NAFLD #FattyLiver

Don't miss the next episode about today's FDA Webcast!